AIM: To examine the gene expression profile of gastric cancer (GC) by combination of laser capture microdissection (LCM) and microarray and to correlate the profiling with histological subtypes. METHODS: Using LCM, pure cancer cells were procured from 45 cancerous tissues. After procurement of about 5000 cells, total RNA was extracted and the quality of RNA was determined before further amplification and hybridization. One microgram of amplified RNA was converted to cDNA and hybridized to cDNA microarray. RESULTS: Among 45 cases, only 21 were qualified for their RNAs. A total of 62 arrays were performed. These included 42 arrays for cancer (21 cases with dye-swab duplication) and 20 arrays for non-tumorous cells (10 cases with dye-swab duplication) with universal reference. Analyzed data showed 504 genes were differentially expressed and could distinguish cancerous and non-cancerous groups with more than 99% accuracy. Of the 504 genes, trefoil factors 1, 2, and 3 were in the list and their expression patterns were consistent with previous reports. Immunohistochemical staining of trefoil factor 1 was also consistent with the array data. Analyses of the tumor group with these 504 genes showed that there were 3 subgroups of GC that did not correspond to any current classification system, including Lauren's classification. CONCLUSION: By using LCM, linear amplification of RNA, and cDNA microarray, we have identified a panel of genes that have the power to discriminate between GC and non-cancer groups. The new molecular classification and the identified novel genes in gastric carcinogenesis deserve further investigations to elucidate their clinicopathological significance.
AIM: To examine the gene expression profile of gastric cancer (GC) by combination of laser capture microdissection (LCM) and microarray and to correlate the profiling with histological subtypes. METHODS: Using LCM, pure cancer cells were procured from 45 cancerous tissues. After procurement of about 5000 cells, total RNA was extracted and the quality of RNA was determined before further amplification and hybridization. One microgram of amplified RNA was converted to cDNA and hybridized to cDNA microarray. RESULTS: Among 45 cases, only 21 were qualified for their RNAs. A total of 62 arrays were performed. These included 42 arrays for cancer (21 cases with dye-swab duplication) and 20 arrays for non-tumorous cells (10 cases with dye-swab duplication) with universal reference. Analyzed data showed 504 genes were differentially expressed and could distinguish cancerous and non-cancerous groups with more than 99% accuracy. Of the 504 genes, trefoil factors 1, 2, and 3 were in the list and their expression patterns were consistent with previous reports. Immunohistochemical staining of trefoil factor 1 was also consistent with the array data. Analyses of the tumor group with these 504 genes showed that there were 3 subgroups of GC that did not correspond to any current classification system, including Lauren's classification. CONCLUSION: By using LCM, linear amplification of RNA, and cDNA microarray, we have identified a panel of genes that have the power to discriminate between GC and non-cancer groups. The new molecular classification and the identified novel genes in gastric carcinogenesis deserve further investigations to elucidate their clinicopathological significance.
Authors: Hark Kyun Kim; Il Ju Choi; Hee Sung Kim; Ju Han Kim; Eugene Kim; In Sook Park; Jong Ho Chun; In-Hoo Kim; Il-Jin Kim; Hio Chung Kang; Jae-Hyun Park; Jae-Moon Bae; Jin Soo Lee; Jae-Gahb Park Journal: Biochem Biophys Res Commun Date: 2004-04-09 Impact factor: 3.575
Authors: M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak Journal: Nature Date: 2000-08-03 Impact factor: 49.962
Authors: C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein Journal: Nature Date: 2000-08-17 Impact factor: 49.962
Authors: Alex Boussioutas; Hong Li; Jia Liu; Paul Waring; Stephen Lade; Andrew J Holloway; Douglas Taupin; Kylie Gorringe; Izhak Haviv; Paul V Desmond; David D L Bowtell Journal: Cancer Res Date: 2003-05-15 Impact factor: 12.701
Authors: G Stemmermann; S C Heffelfinger; A Noffsinger; Y Z Hui; M A Miller; C M Fenoglio-Preiser Journal: Hum Pathol Date: 1994-10 Impact factor: 3.466
Authors: Xiaolin Tian; Ramon U Jin; Andrew J Bredemeyer; Edward J Oates; Katarzyna M Błazewska; Charles E McKenna; Jason C Mills Journal: Mol Cell Biol Date: 2009-12-28 Impact factor: 4.272
Authors: Dylan T Jones; Tanguy Lechertier; Richard Mitter; John M J Herbert; Roy Bicknell; J Louise Jones; Ji-Liang Li; Francesca Buffa; Adrian L Harris; Kairbaan Hodivala-Dilke Journal: PLoS One Date: 2012-10-02 Impact factor: 3.240
Authors: Asaf A Qureshi; Julia C Reis; Nilofer Qureshi; Christopher J Papasian; David C Morrison; Daniel M Schaefer Journal: Lipids Health Dis Date: 2011-02-28 Impact factor: 3.876